Uday Kompella
Founder chez OCUGEN, INC.
Fortune : 1 M $ au 31/03/2024
Profil
Uday B.
Kompella is a Director & Chief Scientific Officer, Independent Director, and Director at Ocugen, Inc. and Ocugen OpCo, Inc. respectively, both founded in 2013.
He is also a Professor-Pharmaceutical Sciences at CU Anschutz Medical Campus.
Dr. Kompella holds a doctorate from the University of Southern California, an undergraduate degree from Birla Institute of Technology & Science, and a graduate degree from Jadavpur University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OCUGEN INC
0,27% | 09/06/2023 | 705 090 ( 0,27% ) | 1 M $ | 31/03/2024 |
Postes actifs de Uday Kompella
| Sociétés | Poste | Début |
|---|---|---|
| OCUGEN, INC. | Founder | 01/01/2013 |
| Ocugen OpCo, Inc. | Founder | 01/09/2013 |
| CU Anschutz Medical Campus | Corporate Officer/Principal | - |
Anciens postes connus de Uday Kompella
| Sociétés | Poste | Fin |
|---|---|---|
Ocugen, Inc. /Old/
 Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Founder | - |
Formation de Uday Kompella
| University of Southern California | Doctorate Degree |
| Birla Institute of Technology & Science | Undergraduate Degree |
| Jadavpur University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OCUGEN, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Health Technology |
| Ocugen OpCo, Inc. |
